Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Deana Mercer

Orthopaedic Surgery Albuquerque, NM Medical Doctor

NPI 1275672263 CMS profile 1026986

Unm Hospital Orthopaedic Surgery, 2211 Lomas Blvd Ne, Albuquerque, NM 87131

Open in the dashboard

General payments

$901,494

611 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$29,467 paid to institutions, not to them · program years 2023–2025

Through program year 2025, Deana Mercer of Albuquerque, NM is reported in the CMS Open Payments database as having received $901,494 across 611 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $29,467 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 98th percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $173,890 121
2024 General $158,194 92
2023 General $132,736 110
2022 General $149,972 87
2021 General $125,183 77
2020 General $43,719 40
2019 General $117,800 84

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Deana Mercer
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Deana Mercer were reported at $173,890. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Deana Mercer Orthopaedic Surgery median Middle half National median
2019 $117,800 $644 $140–$2,844 $163
2020 $43,719 $312 $75–$1,860 $114
2021 $125,183 $520 $117–$2,495 $132
2022 $149,972 $598 $128–$2,731 $149
2023 $132,736 $461 $128–$2,264 $160
2024 $158,194 $497 $134–$2,475 $164
2025 $173,890 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Skeletal Dynamics Inc $516,810 276 payments
  2. AxoGen $363,203 284 payments
  3. Checkpoint Surgical, Inc $12,387 14 payments
  4. Endo Pharmaceuticals Inc. $7,132 10 payments
  5. Smith+Nephew, Inc. $423 6 payments
  6. Kerecis Limited $328 4 payments
  7. FX Shoulder USA, Inc $215 2 payments
  8. Stryker Corporation $213 2 payments
  9. Endo USA, Inc. $142 2 payments
  10. Zimmer Biomet Holdings, Inc. $136 3 payments
  11. Other $504 8 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $456,719 89 payments
  2. Education $132,618 22 payments
  3. Consulting Fee $109,755 48 payments
  4. Royalty or License $59,476 6 payments
  5. Travel and Lodging $48,878 80 payments
  6. Compensation for serving as faculty or as a speaker for a medical education program $37,225 7 payments
  7. Food and Beverage $36,724 341 payments
  8. Honoraria $20,100 18 payments
Products named General payments · program years 2019–2025
  1. IMPlate $516,810 276 payments
  2. IJS $516,810 276 payments
  3. Geminus $516,810 276 payments
  4. Align $516,810 276 payments
  5. Avance Nerve Graft $227,723 184 payments
  6. AXOGUARD NERVE PROTECTOR $195,541 126 payments
  7. AxoGuard Nerve Connector $195,541 126 payments
  8. AXOGUARD HA+ NERVE PROTECTOR $63,148 34 payments
  9. AXOGUARD $62,923 33 payments
  10. AXOGUARD NERVE CAP $62,923 33 payments
  11. Other $178,906 188 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

19

Median for Hand Surgery: 118

Drug cost

$144

Median for Hand Surgery: $615

Branded share of claims

0%

Median for Hand Surgery: 34.5%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Meloxicam Generic 19 $144

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 1,399 Part D prescribers listed as Hand Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 63 billing codes

Paid by Medicare

$78,864

Medicare's payments for the services billed

Medicare patients

217

Average age 71

Services billed

446

137 women, 80 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 69%
High blood pressure 59%
Depression 27%
Osteoporosis 24%
Diabetes 23%
Chronic kidney disease 15%
Ischemic heart disease 14%
COPD 11%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

611 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in New Mexico

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record